학술논문

ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy.
Document Type
Article
Source
Oncogenesis. Nov2018, Vol. 7 Issue 11, p1-13. 13p.
Subject
Language
ISSN
2157-9024